|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 25, 2022
|
FY2021
12 months to Dec 26, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Depreciation and amortization (inclusive of depreciation included in cost of services) | |||||
| Goodwill and intangible asset impairment charge | |||||
| Impairment, Long-Lived Asset, Held-for-Use | |||||
| Provision for credit losses | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Non-cash lease expense | |||||
| Other operating activities | |||||
| Changes in operating assets and liabilities | |||||
| Accounts receivable | |||||
| Income taxes receivable and payable | |||||
| Operating lease right-of-use asset | |||||
| Other assets | |||||
| Accounts payable and other accrued expenses | |||||
| Other accrued wages and benefits | |||||
| Deferred employer payroll taxes | |||||
| Workers’ compensation claims reserve | |||||
| Operating lease liabilities | |||||
| Other liabilities | |||||
| Net cash (used in) provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Divestiture of business | |||||
| Payments for company-owned life insurance | |||||
| Proceeds from company-owned life insurance | |||||
| Purchases of restricted available-for-sale investments | |||||
| Sales of restricted available-for-sale investments | |||||
| Purchases of restricted held-to-maturity investments | |||||
| Sales and maturities of restricted held-to-maturity investments | |||||
| Other | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Purchases and retirement of common stock | |||||
| Net proceeds from employee stock purchase plans | |||||
| Common stock repurchases for taxes upon vesting of restricted stock | |||||
| Net change in revolving credit facility | |||||
| Other | |||||
| Net cash provided by (used in) financing activities | |||||
| Change in cash, cash equivalents and restricted cash and cash equivalents reclassified to assets held-for-sale | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents | |||||
| Net change in cash, cash equivalents and restricted cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash and cash equivalents, beginning of period | |||||
| Cash, cash equivalents and restricted cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest | |||||
| Income taxes, net of refunds | |||||
| Operating lease liabilities | |||||
| Non-cash transactions: | |||||
| Property and equipment purchased but not yet paid | |||||
| Divestiture non-cash consideration | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities |
Loading...